Urologische Universitätsklinik beider Basel
Liestal, 4410, Switzerland
Completed
NCT Number: NCT00681785
Thrombophylaxis in Transurethral Surgery With Dalteparine
The rationale for thrombophrophylaxis is well known. Without prophylaxis the incidence of objectivlely confirmed, hospital-acquired deep venous thrombosis is approximately 10% to 40% among medical or general surgical patients. In urology the prevalence is 15-40%. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy1 recommend against specific prophylaxis in patients undergoing transurethral procedures. Our study is the first double-blind, placebo-controlled study with Dalteparine as thrombophrophylaxis in transurethral surgery. The aim of the study is to proof that thrombophrophylaxis causes not more complications in transurethral surgery than without.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
About this study
The aim of our study is to proof that transurethral surgery under thrombophylaxis with dalteparine is safe. The study design is double-blind placebo controlled.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- transurethral surgery
Exclusion criteria
- oral anticoagulation
Treatment and study plan
dalteparine (Fragmin)
Drugtransurethrals surgery with and without dalteparine
Other names: Dlateparine=Fragmin
Primary outcomes
-
Blood loss
Time frame: intraoperativ, 6 hours post op and 3 days postop
Sponsors and collaborators
Lead sponsor
University Hospital, Basel, Switzerland
Other
Registry information
Official study title
Thromboseprophylaxe Mit Niedermolekularem Heparin Bei Transurethralen Eingriffen
Important dates
- Study start
- 2006
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- May 21, 2008
- Registry last updated
- May 21, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.